BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

631 related articles for article (PubMed ID: 22065093)

  • 1. Vitamin D status in systemic lupus erythematosus patients and its association with selected clinical and laboratory parameters.
    Bogaczewicz J; Sysa-Jedrzejowska A; Arkuszewska C; Zabek J; Kontny E; McCauliffe D; Wozniacka A
    Lupus; 2012 Apr; 21(5):477-84. PubMed ID: 22065093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevalence of autoantibodies directed against 1,25(OH)2D3 in patients with systemic lupus erythematosus].
    Bogaczewicz J; Sysa-Jedrzejowska A; Arkuszewska C; Zabek J; Kontny E; Wozniacka A
    Pol Merkur Lekarski; 2010 Feb; 28(164):103-7. PubMed ID: 20369736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 25-Hydroxyivitamin D3 levels in patients with systemic lupus erythematosus and its association with clinical parameters and laboratory tests.
    Fragoso TS; Dantas AT; Marques CD; Rocha Junior LF; Melo JH; Costa AJ; Duarte AL
    Rev Bras Reumatol; 2012; 52(1):60-5. PubMed ID: 22286646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum 25-OH vitamin D level in treatment-naïve systemic lupus erythematosus patients: Relation to disease activity, IL-23 and IL-17.
    Shahin D; El-Farahaty RM; Houssen ME; Machaly SA; Sallam M; ElSaid TO; Neseem NO
    Lupus; 2017 Aug; 26(9):917-926. PubMed ID: 27927883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-vitamin D, vitamin D in SLE: preliminary results.
    Carvalho JF; Blank M; Kiss E; Tarr T; Amital H; Shoenfeld Y
    Ann N Y Acad Sci; 2007 Aug; 1109():550-7. PubMed ID: 17785344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current daily glucocorticoid use and serum creatinine levels are associated with lower 25(OH) vitamin D levels in Thai patients with systemic lupus erythematosus.
    Chaiamnuay S; Chailurkit LO; Narongroeknawin P; Asavatanabodee P; Laohajaroensombat S; Chaiamnuay P
    J Clin Rheumatol; 2013 Apr; 19(3):121-5. PubMed ID: 23519176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences.
    Ruiz-Irastorza G; Egurbide MV; Olivares N; Martinez-Berriotxoa A; Aguirre C
    Rheumatology (Oxford); 2008 Jun; 47(6):920-3. PubMed ID: 18411213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D levels in Chinese patients with systemic lupus erythematosus: relationship with disease activity, vascular risk factors and atherosclerosis.
    Mok CC; Birmingham DJ; Leung HW; Hebert LA; Song H; Rovin BH
    Rheumatology (Oxford); 2012 Apr; 51(4):644-52. PubMed ID: 21719424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q.
    Mok CC; Birmingham DJ; Ho LY; Hebert LA; Song H; Rovin BH
    Lupus; 2012 Jan; 21(1):36-42. PubMed ID: 21993384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of 25(OH) vitamin D insufficiency and deficiency in chronic kidney disease stage 5 patients on hemodialysis.
    Del Valle E; Negri AL; Aguirre C; Fradinger E; Zanchetta JR
    Hemodial Int; 2007 Jul; 11(3):315-21. PubMed ID: 17576296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of immune status in relation to vitamin D levels in children on regular hemodialysis.
    Youssef DM; Elshal AS; Abo Elazem AA
    Saudi J Kidney Dis Transpl; 2012 Mar; 23(2):267-73. PubMed ID: 22382217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D?
    Amital H; Szekanecz Z; Szücs G; Dankó K; Nagy E; Csépány T; Kiss E; Rovensky J; Tuchynova A; Kozakova D; Doria A; Corocher N; Agmon-Levin N; Barak V; Orbach H; Zandman-Goddard G; Shoenfeld Y
    Ann Rheum Dis; 2010 Jun; 69(6):1155-7. PubMed ID: 20439290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-CD43 and anti-galectin-1 autoantibodies in patients with systemic lupus erythematosus.
    Montiel JL; Monsiváis-Urenda A; Figueroa-Vega N; Moctezuma JF; Burgos-Vargas R; González-Amaro R; Rosenstein Y
    Scand J Rheumatol; 2010; 39(1):50-7. PubMed ID: 20132071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D deficiency in undifferentiated connective tissue disease.
    Zold E; Szodoray P; Gaal J; Kappelmayer J; Csathy L; Gyimesi E; Zeher M; Szegedi G; Bodolay E
    Arthritis Res Ther; 2008; 10(5):R123. PubMed ID: 18928561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships between vitamin D status and cardio-metabolic risk factors in young European adults.
    Muldowney S; Lucey AJ; Paschos G; Martinez JA; Bandarra N; Thorsdottir I; Cashman KD; Kiely M
    Ann Nutr Metab; 2011; 58(2):85-93. PubMed ID: 21474925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients.
    Katsumata Y; Miyake K; Kawaguchi Y; Okamoto Y; Kawamoto M; Gono T; Baba S; Hara M; Yamanaka H
    Arthritis Rheum; 2011 Aug; 63(8):2436-44. PubMed ID: 21506094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-17 in cutaneous lupus erythematosus.
    Tanasescu C; Balanescu E; Balanescu P; Olteanu R; Badea C; Grancea C; Vagu C; Bleotu C; Ardeleanu C; Georgescu A
    Eur J Intern Med; 2010 Jun; 21(3):202-7. PubMed ID: 20493423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of autoantibodies using multiplex methodology in patients with systemic lupus erythematosus.
    Hanly JG; Thompson K; McCurdy G; Fougere L; Theriault C; Wilton K
    J Immunol Methods; 2010 Jan; 352(1-2):147-52. PubMed ID: 19836394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strong association of autoantibodies to human nuclear lamin B1 with lupus anticoagulant antibodies in systemic lupus erythematosus.
    Senécal JL; Rauch J; Grodzicky T; Raynauld JP; Uthman I; Nava A; Guimond M; Raymond Y
    Arthritis Rheum; 1999 Jul; 42(7):1347-53. PubMed ID: 10403261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome.
    Delgado Alves J; Kumar S; Isenberg DA
    Rheumatology (Oxford); 2003 Jul; 42(7):893-9. PubMed ID: 12730551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.